The effect of hydroxycamptothecin and pingyangmycin on human squamous cell carcinoma of the tongue

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 947-952

  Chen, Peng ^a   Liu, Bing ^b   Hu, Ming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Hydroxycamptothecin; Pingyangmycin; Tca8113 cell; Telomerase

Indexed keywords

10 HYDROXYCAMPTOTHECIN; BLEOMYCIN A5; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL STRUCTURE; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; SURVIVAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TONGUE CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

EID: 84872724590     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1109     Document Type: Article

References (22)

1. Miyahara M, Tanuma J, Sugihara K and Semba I: Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 110: 1287-1294, 2007.
2. Huang X, Wei Y, Li L, et al: Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncology 42: 26-30, 2006.
3. Bagan J, Sarrion G and Jimenez Y: Oral cancer: clinical features. Oral Oncol 46: 414-417, 2010.
4. Pederson AW, Haraf DJ, Witt ME, et al: Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. Head Neck 32: 1519-1527, 2010.
5. Kurita H, Yamamoto E, Nozaki S, et al: Multicenter phaseI trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma. Oral Oncol 40: 1000-1006, 2004.
6. Cranmer LD, Engelhardt C and Morgan SS: Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist 15: 1320-1328, 2010.
7. Sun ML, Wang CM and Wen YM: Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi 28: 257-260, 2010 (In Chinese).
8. Li WZ, Wang XY, Li ZG, et al: Celecoxib enhances the lethal effects of bleomycin in human tongue squamous carcinoma cell line Tca8113. Zhonghua Kou Qiang Yi Xue Za Zhi 44: 140-143, 2009 (In Chinese).
9. Xu Y, Luchsinger L, Lucey EC and Smith BD: The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis. Am J Respir Cell Mol Biol 44: 898-905, 2011.
10. Gupta M, Fujimori A and Pommier Y: Eukaryotic DNA topoisomerases I. Biochim Biophys Acta 1262: 1-14, 1995.
11. Saleem A, Ibrahim N, Patel M, et al: Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning. Cancer Res 57: 5100-5106, 1997.
12. Zhang XW, Jiang JF and Xu B: Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma HepG2 cells. Acta Pharmacol Sin 21: 364-368, 2000.
13. Kim NW and Wu F: Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acid Res 25: 2595-2697, 1997.
14. Zhang P, Zhang Y, Mao L, et al: Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. China Journal of Oral and Maxillofacial Surgery 8: 149-153, 2010.
15. Wang LJ, Yan M, Ye DX, et al: Preliminary study on the sphere-forming stem-like cell populations of oral squamous cell carcinoma. Zhongguo Kouqiang Hemian Waike Zazhi 8: 149-153, 2010.
16. Nishikawa T, Nakajima T, Katagishi T, et al: Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation. Liver Int 29: 846-856, 2009.
17. Iliopoulos D, Satra M, Drakaki A, et al: Epigenetic regulation of hTERT promoter in hepatocellular carcinomas. Int J Oncol 34: 391-399, 2009.
18. Saini N, Srinivasan R, Chawla Y, et al: Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int 29: 1162-1170, 2009.
19. Jiang W, Wang XW, Unger T, et al: Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in atelomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer 127: 1011-1020, 2010.
20. Zhu X, Kumar R, Mandal M, et al: Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 93: 6091-6095, 1996.
21. Niculescu T, Weerth S, Soane L, et al: Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1010: 530-533, 2003.
22. Pulera MR, Adams LM, Liu H, et al: Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 29: 2622-2630, 1998.